3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
8
Leukemia, Biphenotypic, Acute
7
Prostatic Neoplasms
4
Burkitt Lymphoma
4
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Leukemia, Myeloid, Acute
2
Recurrence
1
Prostate Cancer Metastatic
1
Neoplasms
1
Neoplasm Metastasis
1
Myelodysplastic Syndromes
1
Lymphoma, T-Cell
1
Leukemia, Myelomonocytic, Juvenile
1
Down Syndrome
1
Interventions
Cyclophosphamide
17
venetoclax
11
fludarabine
10
Cytarabine
10
Mycophenolic Acid
8
Busulfan
7
fludarabine phosphate
6
Whole-Body Irradiation
6
Tacrolimus
5
Methotrexate
5
Daunorubicin
5
Cyclosporine
5
Azacitidine
5
ruxolitinib
4
ponatinib
4
blinatumomab
4
Vincristine
4
Rituximab
4
Peripheral Blood Stem Cell Transplantation
4
Dexamethasone
4
asciminib
3
Mercaptopurine
3
Inotuzumab Ozogamicin
3
Granulocyte Colony-Stimulating Factor
3
Etoposide
3
revumenib
2
quizartinib
2
pegaspargase
2
nilotinib
2
ibrutinib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia
×
Hydrocortisone
×
90 days
×
Clear all
No trials found.